|4Feb 3, 6:23 PM ET

Lee Frank D. 4

4 · Pacira BioSciences, Inc. · Filed Feb 3, 2026

Research Summary

AI-generated summary of this filing

Updated

Pacira (PCRX) CEO Frank D. Lee Withholds 41,488 Shares for Taxes

What Happened
Frank D. Lee, CEO of Pacira BioSciences (PCRX), had 41,488 shares withheld by the company to satisfy tax withholding obligations upon vesting of restricted stock units (RSUs). The shares were valued at $20.54 each, for a total disposition of approximately $852,164. This was a tax-withholding event (routine), not an open-market sale or new purchase.

Key Details

  • Transaction date: January 30, 2026
  • Price per share: $20.54; Total value: ~$852,164
  • Transaction type/code: Shares withheld to cover tax withholding (footnote code F / F1)
  • Shares owned after the transaction: Not specified in the provided filing details
  • Filing date: February 3, 2026 — filed within SEC timing rules (timely)

Context
This was a cashless tax-withholding disposition tied to RSU vesting (company withheld shares instead of the insider remitting cash). Such withholding transactions are routine and do not by themselves indicate a change in the insider’s view of the company.

Insider Transaction Report

Form 4
Period: 2026-01-30
Lee Frank D.
DirectorChief Executive Officer
Transactions
  • Tax Payment

    Common Stock

    [F1]
    2026-01-30$20.54/sh41,488$852,164399,012.841 total
Footnotes (1)
  • [F1]Represents shares withheld by the issuer to cover tax withholding obligations upon vesting of a restricted stock unit award.
Signature
/s/ Kristen Williams, Attorney-in-Fact|2026-02-03

Documents

1 file
  • 4
    wk-form4_1770161015.xmlPrimary

    FORM 4